Changes in subsets and functional exhaustion of CD4+ T cells in spleens of mice infected with Echinococcus multilocularis

doi:10.12140/j.issn.1000-7423.2020.05.013

Abstract

Abstract:

Objective To investigate the effects of different doses of Echinococcus multilocularis infection on splenic CD4⁺ T cell subsets and immune functions in mice. Methods Sixty female C57BL/6 mice were randomly divided into 4 groups, 15 in each group, including sham operation group (saline), low-dose infection group (50 protoscoleces/mouse), medium-dose infection group (500 protoscoleces/mouse), and high-dose infection group (2 000 protoscoleces/mouse). Mice were inoculated via the hepatic portal vein under anaesthetia with different doses of protoscoleces in saline, whereas the control mice were injected with the same volume of saline. Spleens were taken from 5 mice of each group at 2, 12, and 24 weeks after infection, and ground to isolate lymphocytes. Flow cytometry was performed to detect the memory phenotype, the proportions of different subsets, and LAG3 expression in splenic CD4⁺ T cells in different experimental groups. Statistical analysis was performed using Graphad Prism 6.0 software. Results At 2 weeks after infection, the proportions of splenic CD4⁺IFN-γ⁺ T cells in the low- and medium-dose groups were (7.54 ± 1.44)% and (7.58 ± 3.17)%, respectively, which were higher than that in the sham operation group [(3.52 ± 1.03)%, P < 0.05]; and the proportions of splenic CD4⁺TNF-α⁺ T cells were (39.34 ± 4.19)% and (39.53 ± 10.7) %, respectively, which were higher than that of the sham operation group [(22.62 ± 1.50)%, P < 0.01]. At 12 weeks after infection, the proportions of splenic CD4⁺IFN-γ⁺ T cells in the low- and medium-dose groups were (16.52 ± 0.77)% and (22.98± 4.32)%, respectively, which were higher than that in the sham operation group [(16.88 ± 2.49)%, P < 0.05]; the proportions of splenic CD4⁺TNF-α⁺ T cells were (27.26 ± 2.12)% and (28.36 ± 5.24)%, respectively, which were higher than that of the sham operation group [(19.72 ± 3.87)%, P < 0.05]; and the proportions of splenic CD4⁺IL-17A⁺ T cells were (10.70 ± 1.81)% and (11.52 ± 2.68)%, respectively, which were higher than that of the sham operation group [(5.40 ± 1.32)%, P < 0.01]. In addition, the proportions of splenic CD4⁺IL-4⁺ T cells in the low- and medium-dose groups were (2.87 ± 0.84)% and (3.50 ± 0.77)%, respectively, which were higher than that of the sham operation group (1.75 ± 0.83)% (P < 0.01); and the proportions of splenic CD4⁺IL-10⁺ T cells were (4.63 ± 0.78)% and(7.09 ± 2.42)%, respectively, which were higher than that of the sham operation group [(3.03 ± 0.79)%, P < 0.01]. At 24 weeks after infection, the proportions of splenic CD4⁺IFN-γ⁺ T cells, CD4⁺TNF-α⁺ T cells, CD4⁺IL-4⁺ T cells, CD4⁺IL-10⁺ T cells and CD4⁺IL-17A⁺ T cells in the medium- and high-dose groups were all higher than those in the sham operation group (P < 0.05), and the proportion of splenic Treg cells in the high-dose group was higher than that in the sham operation group (P < 0.01). Moreover, at 24 weeks, the proportions of splenic CD4⁺ Treg cells in the three infection groups were all higher than that in the sham operation group; and the proportions of splenic CD4⁺LAG3⁺ T cells in the three infection groups were (16.45 ± 4.89)%, (14.54 ± 4.96)%, and (14.62 ± 2.43)%, respectively, which were higher than that of the sham operation group (8.43 ± 3.46)% (P < 0.05). At 24 weeks after infection, the proportions of LAG3-positive CD4⁺ T cells sereting IFN-γ and TNF-α in the high dose group were (1.67 ± 0.66)% and (0.69 ± 0.27)%, which were significantly lower than those LAG3-negative CD4⁺ T cells[(5.11 ± 1.81)% and(31.7 ± 12.1)%, P < 0.01]. Conclusion After infected with low and medium doses of E. multilocularis, the mice may make advantages of T1 and T17 immune responses to kill and clear the worms, while infection with a high dose of E. multilocularis may lead to imbalance of T1/T2 and T17/Treg type immune responses, and the occurance of CD4⁺ T cells up-regulating the expression of LAG3, resulting in the exhaustion of CD4⁺ T cells and causing chronic alveolar echinococcosis.

Key words: Alveolar echinococcoisis, Spleen, CD4⁺ T cells, Functional exhaustion, Lymphocyte-activation gene 3

CLC Number:

R532.32

HOU Xin-ling, LI Ling-hui, LI Liang, LI Jing, WANG Hui, SHAO Ying-mei, ZHANG Chuan-shan. Changes in subsets and functional exhaustion of CD4⁺ T cells in spleens of mice infected with Echinococcus multilocularis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020, 38(5): 611-618.

Figures/Tables 5

Fig. 1

Table 1

Analysis of splenic CD4+ T cell from mice infected with different doses E. multilocularis protoscoleces at the time points after infection(%)

CD4⁺ T细胞 CD4⁺ T cell	感染后2周2 weeks after infection				感染后12周12 weeks after infection				感染后24周24 weeks after infection
CD4⁺ T细胞 CD4⁺ T cell	假手术组Sham operation group	低剂量组Low-dose infection group	中剂量组Medium-dose infection group	高剂量组 High-dose infection group	假手术组Sham operation group	低剂量组 Low-dose infection group	中剂量组Medium-dose infection group	高剂量组High-dose infection group	假手术组Sham operation group	低剂量组 Low-dose infection group	中剂量组Medium-dose infection group	高剂量组 High-dose infection group
CD4⁺ T_naive	64.00 ± 7.05	61.00 ± 4.77	61.98 ± 10.88	65.48 ± 2.55	64.00 ± 7.05	60.10 ± 6.31	55.78 ± 12.24	52.16 ± 5.81	64.00 ± 7.05	30.18 ± 9.33^b	37.02 ± 7.85^b	29.80 ± 5.89^b
CD4⁺ T_cm	4.73 ± 1.19	5.18 ± 1.88	6.56 ± 1.24	5.72 ± 0.52	4.57 ± 1.13	4.02 ± 0.26	4.18 ± 0.43	3.67 ± 0.71	4.57 ± 1.13	2.82 ± 0.39^b	2.21 ± 0.31^b	1.84 ± 0.30^b
CD4⁺ T_em	27.97 ± 6.33	30.35 ± 3.91	28.38 ± 8.57	26.56 ± 2.28	27.97 ± 6.33	30.65 ± 5.25	35.20 ± 10.86	37.30 ± 5.20	29.28 ± 6.09	55.50 ± 9.14^b	49.60 ± 6.33^b	51.46 ± 4.02^b
CD4⁺IFN-γ⁺ T	3.52 ± 1.03	7.54 ± 1.44^a	7.58 ± 3.17	4.79 ± 0.49	16.88 ± 2.49	16.52 ± 0.77	22.98 ± 4.32^a	18.82 ± 3.81	13.19 ± 3.97	15.95 ± 3.49	27.08 ± 5.72^b	19.40 ± 3.25
CD4⁺ TNF-α⁺ T	22.62 ± 1.50	39.34 ± 4.19^b	39.53 ± 10.74^b	35.02 ± 3.33^a	19.72 ± 3.87	27.26 ± 2.12	28.36 ± 5.24^a	22.32 ± 5.17	18.58 ± 2.85	28.52 ± 4.99	27.16 ± 4.06	37.97 ± 3.35^b
CD4⁺ IL-4⁺ T	1.02 ± 0.52	0.91 ± 0.50	1.14 ± 0.43	0.89 ± 0.46	1.75 ± 0.83	2.87 ± 0.84	3.50 ± 0.77	3.07 ± 1.66	0.70 ± 0.10	1.02 ± 0.47	2.48 ± 0.95^b	2.45 ± 0.84^b
CD4⁺ IL-10⁺ T	5.96 ± 1.09	8.62 ± 2.05	8.89 ± 4.69	5.90 ± 3.83	3.03 ± 0.79	4.64 ± 0.78	7.09 ± 2.42^a	4.63 ± 0.77	2.51 ± 0.23	3.94 ± 1.45	6.0 7 ± 1.46^b	5.59 ± 1.38^b
CD4⁺ IL-17A⁺ T	1.12 ± 0.17	1.40 ± 0.28	1.47 ± 0.34	1.18 ± 0.18	5.40 ± 1.33	10.70 ± 1.81^b	11.52 ± 2.68^b	4.49 ± 1.42	0.34 ± 0.10	0.68 ± 0.43	2.00 ± 0.84^b	1.77 ± 0.72^b
CD4⁺ T_reg	8.58 ± 0.57	7.61 ± 1.02	7.60 ± 0.96	8.03 ± 0.63	9.03 ± 1.18	7.09 ± 1.10^a	7.95 ± 1.23	6.49 ± 0.68^b	7.40 ± 0.82	8.03 ± 0.89	7.25 ± 1.00	9.39 ± 1.08^b
CD4⁺LAG3⁺ T	11.67 ± 1.40	4.97 ± 2.64^b	4.41 ± 1.18^b	10.11 ± 1.21	5.49 ± 3.48	4.52 ± 1.14	9.40 ± 2.43	8.23 ± 5.00	8.43 ± 3.46	16.45 ± 4.89^a	14.54 ± 4.96^a	14.62 ± 2.43^a

Table 1

Fig. 2

Fig. 3

Fig. 4

References 17

[1]	Wen H, Tuerganaili A, Shao YM, et al. Research achievements and challenges for echinococcosis control[J]. Chin J Parasitol Parasit Dis, 2015,33(6):466-471. (in Chinese)
[1]	( 温浩, 吐尔干艾力·阿吉, 邵英梅, 等. 棘球蚴病防治成就及面临的挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015,33(6):466-471.)
[2]	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st Century[J]. Clin Microbiol Rev, 2019,32(2):e00075-e00093.
[3]	Wu WP, Wang H, Wang Q, et al. Sampling survey of echinococcosis in China from 2012 to 2016[J]. Chin J Parasitol Parasit Dis, 2018,36(1):1-14. (in Chinese)
[3]	( 伍卫平, 王虎, 王谦, 等. 2012-2016年中国棘球蚴病抽样调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(1):1-14.)
[4]	Lachenmayer A, Gebbers D, Gottstein B, et al. Elevated incidence of alveolar echinococcosis in immunocompromised patients[J]. Food Waterborne Parasitol, 2019,16:e00060.
[5]	Gottstein B, Wang J, Boubaker G, et al. Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis)[J]. Vet Parasitol, 2015,213:103-109.
[6]	Zhang CS, Shao YM, Yang ST, et al. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model[J]. Sci Rep, 2017,7:11153.
[7]	Zhang C, Lin R, Li Z, et al. Immune exhaustion of T cells in alveolar echinococcosis patients and its reversal by blocking checkpoint receptor TIGIT in a murine model[J]. Hepatology, 2020,71(4):1297-1315.
[8]	Vuitton DA, Gottstein B. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay[J]. JBiomed Biotechnol, 2010,2010:923193.
[9]	Liu HD, Wang HB, Fan HN, et al. Alveolar echinococcosisand immune evasion[J]. Chin J Parasitol Parasit Dis, 2018,36(б):655-660. (in Chinese)
[9]	( 刘寒冬, 王宏宾, 樊海宁, 等. 多房棘球蚴病的免疫逃避机制[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(6):655-660.)
[10]	Wang J, Gottstein B. Immunoregulation in larval Echinococcus -multilocularis infection[J]. Parasite Immunol, 2016,38(3):182-192.
[11]	Bauder B, Auer H, Schilcher F, et al. Experimental investigationson the B andTcellimmune response in primary alveolarechinococcosis[J]. Parasite Immunol, 1999,21(8):409-421.
[12]	Wang J, Müller s, et al. Depletion of FoxP3 (+)Tregs improves control of larval Echinococcus multilocularisinfection by promoting co-stimulation and ThI/17 immunity[J]. Immun Inflamm Dis, 2017,5(4):435-447.
[13]	Jittimanee J, Sermswan RW, Puapairoj A, et al. Cytok in expression hamsters experimentally infected with Opisthorchis viverrini[J]. Parasite Immunol, 2007,29(3):159-67.
[14]	Bellanger AР, Courquet S, Pallandre JR, et al. Echinococcus-multilocularis vesicular fluid induces the expression of immunecheckpoint proteins in vitro[J]. Parasite Immunol, 2020,14:e12711.
[15]	Dyck L, Mills KHG. Immune checkpoints and their inhibition cancer and infectious diseases[J]. Eur J Immunol, 2017,47(5):765-779.
[16]	Kurup SP, Obeng-Adjei N, Anthony SM, et al. Regulatory Tcells impede acute and long-term immunity to blood-stagemalaria through CTLA-4[J]. Nat Med, 2017,23(10):1220-1225.
[17]	Taylor MD, Harris A, Babayan SA, et al. CTLA-4 and CD4*CD25· regulatory T cells inhibit roeetive immunity to filarialparasites in vivo[J]. J Immunol, 2007,179(7):4626-4634.